Measures of Short-term Test-retest Reliability of Computerized Neurobehavioral Tests
Overview
Neurology
Toxicology
Affiliations
Neurobehavioral test batteries are often administered repeatedly to evaluate changes over time or effects of clinical interventions or neurotoxic exposures. Time intervals between test sessions range from very short (hours) to very long (decades). The aim of this study was to compare the impact of two brief time intervals on the test-retest reliability of frequently used neurobehavioral tests. Fifty healthy adults were recruited through newspaper advertisements in Portland, Oregon. Participants were divided into either a 6h (same-day) or 1-week retest group. All participants completed a battery of tests from the computerized Behavioral Assessment and Research System (BARS). Reliability was assessed by Pearson product-moment correlation and by intraclass correlation coefficient (ICC). The test battery generally showed adequate reliability in the short-term (week) and very short-term (day) and stability in performance over repeated administration when examined by multiple measures. Intraclass correlation coefficient ranged from 0.35 to 0.85. The magnitude of variation of performance in the administered tests was equally distributed around zero (i.e. no difference). The findings suggest that neurobehavioral tests such as BARS may be a useful tool for the assessment of acute exposures and clinical status where short-term evaluation is required (e.g. in the same-day or within 1 week).
Sears L, Smith M, Cai L, Zierold K Neurotoxicology. 2024; 103:78-86.
PMID: 38871300 PMC: 11378984. DOI: 10.1016/j.neuro.2024.06.005.
The reliability of neurobehavioral tests in a thai adult population.
Thammachai A, Sapbamrer R, Rohitrattana J, Tongprasert S, Hongsibsong S, Wangsan K Dement Neuropsychol. 2023; 16(3):324-331.
PMID: 36619834 PMC: 9762389. DOI: 10.1590/1980-5764-DN-2021-0115.
Sears L, Sears C, Myers J, Brock G, Zierold K Neurotoxicology. 2020; 81:11-17.
PMID: 32810513 PMC: 7708521. DOI: 10.1016/j.neuro.2020.08.002.
Tanshinone IIA improves hypoxic ischemic encephalopathy through TLR‑4‑mediated NF‑κB signal pathway.
Fang C, Xie L, Liu C, Fu C, Ye W, Liu H Mol Med Rep. 2018; 18(2):1899-1908.
PMID: 29956801 PMC: 6072156. DOI: 10.3892/mmr.2018.9227.
Adaptation of a neurobehavioral test battery for Thai children.
Rohitrattana J, Siriwong W, Suittiwan P, Robson M, Ohman Strickland P, Rohlman D Rocz Panstw Zakl Hig. 2014; 65(3):205-12.
PMID: 25247800 PMC: 4243443.